Who will maintain as long-term responders more than 3 years with first- or second-generation EGFR TKI among EGFR mutant NSCLC?

Yeo, JH; Park, SH; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

ANNALS OF ONCOLOGY, 2020; 31 (): S885